VRP-Clinic Software Evaluation - in Support of Rehabilitation (VRP02) (VRP02)

September 21, 2018 updated by: VRHealth Group Ltd

Evaluation of the Performance of VRP-Clinic in Healthy Subjects in the Support of Rehabilitation

The current study is designed to evaluate neck movements performed according to the VRP-Clinic software, and to verify that they promote physical activities that correspond with physical rehabilitation.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

The study will take place at Shaare Zedek Medical Center (SZMC). The study will include a single visit.

Each subject will put on the VR headset and perform a series of neck movements guided by graphic instructions appearing in the VR environment. The session will be recorded with a video camera which will subsequently be viewed and evaluated by clinicians. The clinicians will identify each movement seen on the video from a predefined list and determine if such a movement is recommended as part of a rehabilitation training program.

Study Type

Interventional

Enrollment (Actual)

20

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Jerusalem, Israel, 9103102
        • Shaare Zedek Medical Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. Healthy male or female
  2. Age 18-65

Exclusion Criteria:

  1. History of neck related disorders (Whiplash, disc degeneration disease or other acute cervical spine conditions)
  2. Current neck pain
  3. Under medical treatment or observation for any health-related issue during the study
  4. Recent trauma
  5. Oncology background
  6. Acute disease/illness
  7. Pregnancy.
  8. Using drugs that could potentially affect physical function and balance (such as corticosteroids, antipsychotics or antidepressants)
  9. Vision problems that require glasses (not all frame types can fit into the headset)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: VRP-Clinic
VRP-Clinic software on a virtual reality platform
Subjects will perform a series of neck movements guided by graphic instructions appearing in the virtual reality environment

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of VRP-Clinic Neck Movements That the Assessing Clinician Recognizes as Rehabilitation Movements
Time Frame: Up to 2 weeks after the session

The movements are recorded on video and sent to clinicians for evaluation after the session is completed.

The movements are then evaluated by the clinicians according to a predetermined list.

Up to 2 weeks after the session

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of Participants With Any Adverse Event Occurring During the Study
Time Frame: through study completion, an average of 2 weeks
Safety measure - The number of participants with any adverse event reported by the subject or observed by the investigator/clinician during the study will be recorded.
through study completion, an average of 2 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Lilach Gavish, PhD, Hebrew University of Jerusalem
  • Principal Investigator: Yair Barzilay, MD, Shaare Zedek Medical Center

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 3, 2017

Primary Completion (Actual)

July 18, 2017

Study Completion (Actual)

August 10, 2017

Study Registration Dates

First Submitted

April 3, 2017

First Submitted That Met QC Criteria

April 3, 2017

First Posted (Actual)

April 7, 2017

Study Record Updates

Last Update Posted (Actual)

September 25, 2018

Last Update Submitted That Met QC Criteria

September 21, 2018

Last Verified

September 1, 2018

More Information

Terms related to this study

Other Study ID Numbers

  • VRP02-0076-17-SZMC

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Rehabilitation

Clinical Trials on VRP-Clinic

3
Subscribe